A Bahrain study shows CT scans to check for blood clots in lung blood vessels increased significantly in people with sickle ...

A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.

The report covers 40+ companies and 50+ pipeline drugs. Explore drug profiles from clinical to nonclinical stages, assessment by product type, and detailed pipeline development activities. Key players ...

More perceived social support from classmates was tied to less disease severity in children with sickle cell anemia in Nigeria, per a study.

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

In the phase 1 RESTORE trial, the aim is to test not only the safety of the lab-grown cells, but also their lifespan in the body compared to infusions of standard red blood cells from the same donor.

In-depth Adakveo market analysis highlights its size, growth potential, and segmentation, covering major regions and countries. Rising sickle cell disease prevalence, increasing healthcare expenditure ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD ... painful attacks that occur when red blood cells become misshapen and block blood vessels ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

Representatives from the American Red Cross and Vitalant Blood Donation hosted organization leaders on campus for an ...

Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...